Showing results (11-20 of 179) with videos related to
Sort By:
Pageof 18
Expert Opinion on Biological Therapy|December 4, 2012
Aflibercept in lung cancerJoel W Neal, Heather A WakeleeBiologics : Targets & Therapy|October 12, 2012
First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitorsKim-Son H Nguyen, Joel W NealTranslational Lung Cancer Research|March 26, 2015
MET inhibitors in combination with other therapies in non-small cell lung cancerSukhmani Padda, Joel W Neal, Heather A WakeleeClinical Lung Cancer|February 11, 2015
Relationship of Driver Oncogenes to Long-Term Pemetrexed Response in Non--Small-Cell Lung CancerYing Liang, Heather A Wakelee, Joel W NealThe Annals of Thoracic Surgery|January 4, 2015
Unicentric, multifocal Castleman disease of the mediastinum associated with cerebellitisMasatsugu Hamaji, Joel W Neal, Bryan M BurtClinics in Chest Medicine|November 8, 2011
Current management of small cell lung cancerJoel W Neal, Matthew A Gubens, Heather A WakeleeNature Reviews. Clinical Oncology|December 24, 2014
Developing biomarker-specific end points in lung cancer clinical trialsJoel W Neal, Justin F Gainor, Alice T ShawAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 27, 2017
Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?Wafik S El-Deiry, Barry Taylor, Joel W NealWorld Journal of Clinical Oncology|October 11, 2014
Review of the current targeted therapies for non-small-cell lung cancerKim-Son H Nguyen, Joel W Neal, Heather WakeleeCurrent Treatment Options in Oncology|September 5, 2015
Management of Dermatologic Complications of Lung Cancer TherapiesSilvina B Pugliese, Joel W Neal, Bernice Y KwongPageof 18